Is obeticholic acid a prescription drug?

Obeticholic acid (Obeticholic acid) is a drug primarily used to treat certain liver diseases. It is a farnesoid

The main indication for obeticholic acid is primary biliary cholangitis (PBC), a chronic autoimmune liver disease characterized by progressive destruction of intrahepatic bile ducts, leading to cholestasis and impaired liver function. Obeticholic acid is an important treatment option for patients with PBC who have a poor response to or intolerance to ursodeoxycholic acid (UDCA) therapy. Studies have shown that liver function indicators such as alkaline phosphatase (ALP) levels are significantly reduced in patients treated with obeticholic acid, which is important for assessing disease progression and treatment efficacy.

Obeticholic acid is a prescription drug and must be used under the guidance of a doctor. Due to its strong pharmacological effects and potential adverse reactions, detailed evaluation and monitoring are required before use. Common side effects include itching, fatigue, abdominal pain, etc. A few patients may have severe liver function abnormalities, so liver function tests need to be performed regularly during treatment.

In addition, the use of obeticholic acid requires monitoring of the patient's liver function and regular blood tests to ensure the safety and effectiveness of the drug. Obeticholic acid may interact with other drugs, and caution should be exercised when used in combination with certain cholesterol-lowering drugs and immunosuppressants. Patients should strictly abide by the doctor's advice during use and are not allowed to adjust the dosage or stop taking the medicine on their own.

In general, obeticholic acid provides a new treatment option for PBC patients, but its use must be carried out under the supervision of professional doctors to ensure safety and efficacy.

Reference materials:https://go.drugbank.com/drugs/DB05990